PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Tuberculosis and Respiratory Diseases10.4046/trd.2018.0004201982162Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung AdenocarcinomaSeo Yun Kim, Jae Kyung Myung, Hye-Ryoun Kim, Im Il Na, Jae Soo Koh, Hee Jong Baek, Cheol Hyeon Kimhttps://synapse.koreamed.org/pdf/10.4046/trd.2018.0004, https://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2018.0004, https://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2018.0004
OncoTargets and Therapy10.2147/ott.s957852016355Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutationsYan Li, Ruiguang Zhang, Xiu Nie, Xiaorong Dong, Gang Wuhttps://www.dovepress.com/getfile.php?fileID=28682
Lung Cancer10.1016/j.lungcan.2015.06.0082015893337-342Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patientsLing Shan, Ziping Wang, Lei Guo, Hongyan Sun, Tian Qiu, Yun Ling, Wenbin Li, Lin Li, Xiuyun Liu, Bo Zheng, Ning Lu, Jianming Yinghttps://api.elsevier.com/content/article/PII:S0169500215002937?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0169500215002937?httpAccept=text/xml
OncoTargets and Therapy10.2147/ott.s2795402021Volume 1313425-13435The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI TherapyWen-Chien Cheng, Te-Chun Hsia, Chih-Yen Tu, Hung-Jen Chenhttps://www.dovepress.com/getfile.php?fileID=65345, https://www.dovepress.com/getfile.php?fileID=65345
Lung Cancer10.1016/j.lungcan.2013.07.0182013821177-178NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKIFrancesco Facchinetti, Marcello Tiseo, Letizia Gnetti, Enrico Maria Silini, Andrea Ardizzonihttps://api.elsevier.com/content/article/PII:S0169500213003279?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213003279?httpAccept=text/plain
Lung Cancer: Targets and Therapy10.2147/lctt.s1243012017Volume 821-30Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective studySeigo Minami, Yoshitaka Ogata, Shouichi Ihara, Suguru Yamamoto, Kiyoshi Komutahttps://www.dovepress.com/getfile.php?fileID=35098, https://www.dovepress.com/getfile.php?fileID=35098
Annals of Oncology10.1093/annonc/mdx671.017201728x130Different first line EGFR-TKI regimen and the clearance of EGFR sensitive mutation in acquired EGFR-TKI resistant lung adenocarcinoma patientsW. Zhuang, C. Xu, W. Wang, Z. Song, Y. Zhu, R. Chen, Y. Guan, X. Yi, M. Fang, G. Chen, T. Lv, Y. Songhttps://api.elsevier.com/content/article/PII:S092375341956402X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092375341956402X?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/28/suppl_10/mdx671.017/21936922/mdx671.017.pdf
Journal of Experimental & Clinical Cancer Research10.1186/1756-9966-31-652012311Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFRFen Wang, , Shuhang Wang, Zhijie Wang, Jianchun Duan, Tongtong An, Jun Zhao, Hua Bai, Jie Wanghttp://link.springer.com/content/pdf/10.1186/1756-9966-31-65.pdf, http://link.springer.com/article/10.1186/1756-9966-31-65/fulltext.html, http://link.springer.com/content/pdf/10.1186/1756-9966-31-65.pdf
10.21203/rs.3.rs-578508/v12021Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC in Traditionally Unresectable PatientsKe-Cheng Chen, Shuenn-Wen Kuo, Chen-Hao Hsiao, Jing-Shing Chenhttps://www.researchsquare.com/article/rs-578508/v1, https://www.researchsquare.com/article/rs-578508/v1.html
OncoTargets and Therapy10.2147/ott.s1266132017Volume 10447-452Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinomaShen-Cun Fang, Hai-Tao Zhang, Ying-Ming Zhang, Wei-Ping Xiehttps://www.dovepress.com/getfile.php?fileID=34502, https://www.dovepress.com/getfile.php?fileID=34502